Norepinephrine
- Product NDC
- 81298-9658
- 11-digit product format
- 812989658
- Labeler code
- 81298
- Product ID
- 81298-9658_329c5273-4dc5-4738-bf21-660e73d91eb9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Norepinephrine Bitartrate
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Long Grove Pharmaceuticals, LLC
- Application
- NDA214628
- Marketing category
- NDA
- Marketing start
- 2024-02-02
- Substance
- NOREPINEPHRINE BITARTRATE
- Active strength
- 64 ug/mL
- Pharmacologic classes
- Catecholamine [EPC], Catecholamines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE | EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | |
| N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | |
| N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N214628-001 | 10159657 | 2038-01-30 | Drug product | 2022-11-02 | |
| N214628-001 | 10226436 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 |
| N214628-001 | 10420735 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 |
| N214628-001 | 10568850 | 2038-01-30 | Drug product | 2022-11-02 | |
| N214628-001 | 11413259 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 |
| N214628-001 | 11602508 | 2038-01-30 | Drug product | 2023-03-14 | |
| N214628-001 | 12245996 | 2038-01-30 | Drug product | 2025-03-26 | |
| N214628-002 | 10159657 | 2038-01-30 | Drug product | 2022-11-02 | |
| N214628-002 | 10226436 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 |
| N214628-002 | 10420735 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 |
| N214628-002 | 10568850 | 2038-01-30 | Drug product | 2022-11-02 | |
| N214628-002 | 11413259 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 |
| N214628-002 | 11602508 | 2038-01-30 | Drug product | 2023-03-14 | |
| N214628-002 | 12245996 | 2038-01-30 | Drug product | 2025-03-26 | |
| N214628-003 | 10159657 | 2038-01-30 | Drug product | 2022-11-02 | |
| N214628-003 | 10226436 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 |
| N214628-003 | 10420735 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 |
| N214628-003 | 10568850 | 2038-01-30 | Drug product | 2022-11-02 | |
| N214628-003 | 11413259 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 |
| N214628-003 | 11602508 | 2038-01-30 | Drug product | 2023-03-14 | |
| N214628-003 | 12245996 | 2038-01-30 | Drug product | 2025-03-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N214628-002 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N214628-003 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N214628-001 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-10-06 | 8072bd15b7f6… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N214628-001 | 10159657 | 2038-01-30 | Drug product | 2022-11-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-001 | 10226436 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-001 | 10420735 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-001 | 10568850 | 2038-01-30 | Drug product | 2022-11-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-001 | 11413259 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-001 | 11602508 | 2038-01-30 | Drug product | 2023-03-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-001 | 12245996 | 2038-01-30 | Drug product | 2025-03-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-002 | 10159657 | 2038-01-30 | Drug product | 2022-11-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-002 | 10226436 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-002 | 10420735 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-002 | 10568850 | 2038-01-30 | Drug product | 2022-11-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-002 | 11413259 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-002 | 11602508 | 2038-01-30 | Drug product | 2023-03-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-002 | 12245996 | 2038-01-30 | Drug product | 2025-03-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-003 | 10159657 | 2038-01-30 | Drug product | 2022-11-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-003 | 10226436 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-003 | 10420735 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-003 | 10568850 | 2038-01-30 | Drug product | 2022-11-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-003 | 11413259 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-003 | 11602508 | 2038-01-30 | Drug product | 2023-03-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214628-003 | 12245996 | 2038-01-30 | Drug product | 2025-03-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-001 | 10159657 | 2038-01-30 | Drug product | 2022-11-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-001 | 10226436 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-001 | 10420735 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-001 | 10568850 | 2038-01-30 | Drug product | 2022-11-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-001 | 11413259 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-001 | 11602508 | 2038-01-30 | Drug product | 2023-03-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-001 | 12245996 | 2038-01-30 | Drug product | 2025-03-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-002 | 10159657 | 2038-01-30 | Drug product | 2022-11-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-002 | 10226436 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-002 | 10420735 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-002 | 10568850 | 2038-01-30 | Drug product | 2022-11-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-002 | 11413259 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-002 | 11602508 | 2038-01-30 | Drug product | 2023-03-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-002 | 12245996 | 2038-01-30 | Drug product | 2025-03-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-003 | 10159657 | 2038-01-30 | Drug product | 2022-11-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-003 | 10226436 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-003 | 10420735 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-003 | 10568850 | 2038-01-30 | Drug product | 2022-11-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214628-003 | 11413259 | 2038-01-30 | U-3461 | Drug product | 2022-11-02 | 31067a03dcf5… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Norepinephrine
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NOREPINEPHRINE BITARTRATE | 64 ug/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| IFY5PE3ZRW | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 759807dd-61a8-4f6f-8bf5-f6ee773c81bc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2ab36713-99a4-1d04-c42f-907afc73b6f9 | Product name | 7 | 20260105 |
| 209a4db0-2639-413d-9ad3-274ad7be11f7 | Product name | 1 | 20230912 |
| 08ddeef6-6d79-428b-a00b-432b50fc2b32 | Product name | 1 | 20230831 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81298-9658-1 | Norepinephrine | 250 mL in 1 BAG | SOLUTION | 250 | 2 | |
| 81298-9658-1 | Norepinephrine | 1 in 1 POUCH | SOLUTION | 1 | 2 | |
| 81298-9658-3 | Norepinephrine | 10 in 1 BOX | SOLUTION | 10 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81298-9658-1 | ML - Milliliter | 81298-9658 | be5bd178-fd61-488f-ad19-b577fc316947 | 1 | 2024-06-10 |
| 81298-9658-3 | ML - Milliliter | 81298-9658 | 48b0933e-bb7e-4890-9064-814d008a279a | 1 | 2024-06-10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 81298-9658 | NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) SOLUTION [LONG GROVE PHARMACEUTICALS, LLC] | 1 | Current NDC, 3 package rows | 20240202_759807dd-61a8-4f6f-8bf5-f6ee773c81bc.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Norepinephrine | NOREPINEPHRINE BITARTRATE | Long Grove Pharmaceuticals, LLC | 759807dd-61a8-4f6f-8bf5-f6ee773c81bc | 2025-12-04 | Warnings, Adverse reactions | 214628 NDA214628 81298-9658 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2619579 | norepinephrine bitartrate 16 MG in 250 ML Injection | PSN | 759807dd-61a8-4f6f-8bf5-f6ee773c81bc | 2 |
| 2475337 | norepinephrine bitartrate 4 MG in 250 ML Injection | PSN | 759807dd-61a8-4f6f-8bf5-f6ee773c81bc | 2 |
| 2475340 | norepinephrine bitartrate 8 MG in 250 ML Injection | PSN | 759807dd-61a8-4f6f-8bf5-f6ee773c81bc | 2 |
| 2475337 | 250 ML norepinephrine 0.016 MG/ML Injection | SCD | 759807dd-61a8-4f6f-8bf5-f6ee773c81bc | 2 |
| 2475340 | 250 ML norepinephrine 0.032 MG/ML Injection | SCD | 759807dd-61a8-4f6f-8bf5-f6ee773c81bc | 2 |
| 2619579 | 250 ML norepinephrine 0.064 MG/ML Injection | SCD | 759807dd-61a8-4f6f-8bf5-f6ee773c81bc | 2 |
| 2619579 | norepinephrine (as bitartrate) 16 MG per 250 ML Injection | SY | 759807dd-61a8-4f6f-8bf5-f6ee773c81bc | 2 |
| 2475337 | norepinephrine (as bitartrate) 4 MG per 250 ML Injection | SY | 759807dd-61a8-4f6f-8bf5-f6ee773c81bc | 2 |
| 2475340 | norepinephrine (as bitartrate) 8 MG per 250 ML Injection | SY | 759807dd-61a8-4f6f-8bf5-f6ee773c81bc | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 81298-9658-1 | 81298965801 | 250 mL in 1 BAG | 250 ml | Historical | |||
| 81298-9658-3 | 81298965803 | 10 POUCH in 1 BOX (81298-9658-3) / 1 BAG in 1 POUCH (81298-9658-1) / 250 mL in 1 BAG | 10 pouch | 2024-02-02 | No | No | Current |